HRSA 340B Rebate Model RFI: Comment Deadline April 20, Possible Expansion to All IRA Drugs
Issue
After a Maine federal court vacated the original 340B rebate pilot program, HRSA is gathering stakeholder input with a 60-day comment window closing April 20. HRSA has signaled it may expand the rebate model to ALL drugs selected for Medicare price negotiation under the IRA through 2027.
FQHCs that depend on 340B upfront discounts for cash flow could face a shift to delayed rebate payments — a devastating change for smaller FQHCs without reserves.
Sources for this story
Federal Register / HRSASources for your board packet
This story's source plus 4 related stories and their sources, ready to print for your team or board.
Free. Unlocking the packet subscribes you to Intel Brief. You'll be subscribed right away, with no confirmation email. Unsubscribe with one click in any issue. If you unsubscribed before, we won't re-add you. We never sell your email. You can open each source above without an email.
Part of
- 340B drug pricing
HRSA's rebate model pilot
FQHC Talent. (2026, April 20). HRSA 340B Rebate Model RFI: Comment Deadline April 20, Possible Expansion to All IRA Drugs. Source: Federal Register / HRSA. Retrieved October 6, 2026, from https://www.fqhctalent.com/intel/hrsa-340b-rebate-rfi-april-20-deadline